|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 23 January 2003
doi: 10.1242/jcs.00281
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Department of Radiation and Cellular Oncology, University of Chicago, Chicago,
IL 60637, USA
2 Section of Neurosurgery, University of Chicago, Chicago, IL 60637, USA
3 Department of Neurosurgery, University of California San Francisco, San
Francisco, CA 94143, USA
* Author for correspondence (e-mail: rrw{at}rover.uchicago.edu)
Accepted 19 November 2002
Tumour angiogenesis is a complex process based upon a sequence of interactions between tumour cells and endothelial cells. To model tumour/endothelial-cell interactions, we co-cultured U87 human glioma cells with human umbilical vein endothelial cells (HUVECs). U87 cells induced an `activated' phenotype in HUVECs, including an increase in proliferation, migration and net-like formation. Activation was observed in co-cultures where cells were in direct contact and physically separated, suggesting an important role for soluble factor(s) in the phenotypic and genotypic changes observed. Expressional profiling of tumour-activated endothelial cells was evaluated using cDNA arrays and confirmed by quantitative PCR. Matching pairs of receptors/ligands were found to be coordinately expressed, including TGFßRII with TGFß3, FGFRII and cysteine-rich fibroblast growth factor receptor (CRF-1) with FGF7 and FGF12, CCR1, CCR3, CCR5 with RANTES and calcitronin receptor-like gene (CALCRL) with adrenomedullin. Consistent with cDNA array data, immunohistochemical staining of expressed proteins revealed the upregulation of Tie-2 receptor in vitro and in vivo. Our data suggest that tumour-induced activation of quiescent endothelial cells involves the expression of angiogenesis-related receptors and the induction of autocrine growth loops. We suggest that tumour cells release growth factors that induce endothelial cells to express specific ligands and their cognate receptors coordinately.
Key words: Angiogenesis, Expressional profiling, Intercellular communication and activation, Autocrine loops
Related articles in JCS:
This article has been cited by other articles:
![]() |
J. Hong, R. C. Doebele, M. W. Lingen, L. A. Quilliam, W.-J. Tang, and M. R. Rosner Anthrax Edema Toxin Inhibits Endothelial Cell Chemotaxis via Epac and Rap1 J. Biol. Chem., July 6, 2007; 282(27): 19781 - 19787. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Meleth, E. Agron, C.-C. Chan, G. F. Reed, K. Arora, G. Byrnes, K. G. Csaky, F. L. Ferris III, and E. Y. Chew Serum Inflammatory Markers in Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4295 - 4301. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. van Deventer, W. O'Connor Jr., W. J. Brickey, R. M. Aris, J. P.Y. Ting, and J. S. Serody C-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary Metastasis Cancer Res., April 15, 2005; 65(8): 3374 - 3379. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Khodarev, M. Beckett, E. Labay, T. Darga, B. Roizman, and R. R. Weichselbaum STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells PNAS, February 10, 2004; 101(6): 1714 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Strasly, G. Doronzo, P. Capello, D. Valdembri, M. Arese, S. Mitola, P. Moore, G. Alessandri, M. Giovarelli, and F. Bussolino CCL16 activates an angiogenic program in vascular endothelial cells Blood, January 1, 2004; 103(1): 40 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Walter-Yohrling, X. Cao, M. Callahan, W. Weber, S. Morgenbesser, S. L. Madden, C. Wang, and B. A. Teicher Identification of Genes Expressed in Malignant Cells That Promote Invasion Cancer Res., December 15, 2003; 63(24): 8939 - 8947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vacca, R. Ria, F. Semeraro, F. Merchionne, M. Coluccia, A. Boccarelli, C. Scavelli, B. Nico, A. Gernone, F. Battelli, et al. Endothelial cells in the bone marrow of patients with multiple myeloma Blood, November 1, 2003; 102(9): 3340 - 3348. [Abstract] [Full Text] [PDF] |
||||